research, with a significant CVD burden. Our study specifically examines the influence of VEGFi therapy (sunitinib and sorafenib) on LVSD and blood pressure among AYAs undergoing adjuvant therapy for unfavorable, high-risk renal cell carcinoma. Our main
Search Results
Cardiovascular Implications of Vascular Endothelial Growth Factor Inhibition Among Adolescents/Young Adults in ECOG-ACRIN E2805
Wendy J. Bottinor, Yael Flamand, Naomi B. Haas, Anne M. ONeill, Robert S. DiPaola, Pearl Subramanian, David Cella, W. Gregory Hundley, Lynne I. Wagner, John M. Salsman, and Bonnie Ky
Management of Patients With Resectable and Metastatic Non–Small Cell Lung Cancer
Presented by: Jane Yanagawa and Gregory J. Riely
would benefit from adjuvant therapy after lung resection. There are several ongoing adjuvant clinical trials exploring different combinations of targeted therapies and immunotherapies with or without chemotherapy, and additional studies are examining the
Impact of Facility Surgical Volume on Survival in Patients With Cancer
Kelsey C. Stoltzfus, Biyi Shen, Leila Tchelebi, Daniel M. Trifiletti, Niraj J. Gusani, Vonn Walter, Ming Wang, and Nicholas G. Zaorsky
and medical oncologists, for opinions regarding definitive radiation therapy or early adjuvant therapy. 24 , 25 Finally, high-volume facilities tend to have good advanced procedure care (eg, ICU care, postsurgical therapy), both preoperatively and
Use of Endobronchial Ultrasound and Endoscopic Ultrasound to Stage the Mediastinum in Early-Stage Lung Cancer
Christopher Gilbert, Lonny Yarmus, and David Feller-Kopman
2 disease at the time of resection and receive adjuvant therapy, most institutions and professional guidelines continue to endorse that those with suspected early-stage NSCLC and low suspicion of advanced nodal disease be referred straight to the
Clinical Response to T-DM1 in HER2-Amplified, KRAS-Mutated Metastatic Colorectal Cancer
Jaideep Sandhu, Chongkai Wang, and Marwan Fakih
chemoradiation to the pelvis and low anterior resection. No further adjuvant therapy was warranted. The patient remained in clinical remission for 5 months, when a PET/CT in comparison with the postsurgical CT scan revealed an FDG-avid enlarged right midabdominal
A Novel Clinically Based Staging System for Gallbladder Cancer
Siddhartha Yadav, Sri Harsha Tella, Anuhya Kommalapati, Kristin Mara, Kritika Prasai, Mohamed Hamdy Mady, Mohamed Hassan, Rory L. Smoot, Sean P. Cleary, Mark J. Truty, Lewis R. Roberts, and Amit Mahipal
proposed nomograms to determine the role of adjuvant therapy (radiation or chemoradiation) in node-positive GBC. 11 , 12 Although all of these nomograms were shown to be superior compared with the AJCC TNM staging system, they all used data from the
Survivorship: Nutrition and Weight Management, Version 2.2014
Crystal S. Denlinger, Jennifer A. Ligibel, Madhuri Are, K. Scott Baker, Wendy Demark-Wahnefried, Don Dizon, Debra L. Friedman, Mindy Goldman, Lee Jones, Allison King, Grace H. Ku, Elizabeth Kvale, Terry S. Langbaum, Kristin Leonardi-Warren, Mary S. McCabe, Michelle Melisko, Jose G. Montoya, Kathi Mooney, Mary Ann Morgan, Javid J. Moslehi, Tracey O’Connor, Linda Overholser, Electra D. Paskett, Jeffrey Peppercorn, Muhammad Raza, M. Alma Rodriguez, Karen L. Syrjala, Susan G. Urba, Mark T. Wakabayashi, Phyllis Zee, Nicole R. McMillian, and Deborah A. Freedman-Cass
sweets was found to be associated with improved outcomes in terms of cancer recurrence and death, and in overall survival. 27 Recent analysis of a stage III colon cancer adjuvant therapy trial found that higher dietary glycemic load (associated with high
PTCH1 Mutation in a Patient With Metastatic Undifferentiated Carcinoma With Clear Cell Change
Katy K. Tsai, Neharika Khurana, Timothy McCalmont, Adil Daud, Boris Bastian, and Iwei Yeh
noted. No adjuvant therapy was administered. On clinical examination at his June 2015 visit, the patient had soft tissue swelling over his right trapezius with ipsilateral supraclavicular lymphadenopathy. PET/CT performed on July 10, 2015, confirmed the
Role of Locoregional Treatment in Vulvar Cancer With Pelvic Lymph Node Metastases: Time to Reconsider FIGO Staging?
Ashwin Shinde, Richard Li, Arya Amini, Yi-Jen Chen, Mihaela Cristea, Wenge Wang, Mark Wakabyashi, Ernest Han, Catheryn Yashar, Kevin Albuquerque, Sushil Beriwal, and Scott Glaser
2015 ; 139 : 458 – 464 . 10.1016/j.ygyno.2015.09.081 26432039 10. Mahner S , Jueckstock J , Hilpert F , . Adjuvant therapy in lymph node-positive vulvar cancer: the AGO-CaRE-1 study . J Natl Cancer Inst 2015 ; 107 : dju426 . 25618900 10
Quality of Life Is Associated With Survival in Patients With Gastric Cancer: Results From the Randomized CRITICS Trial
Romy M. van Amelsfoort, Iris Walraven, Jacobien Kieffer, Edwin P.M. Jansen, Annemieke Cats, Nicole C.T. van Grieken, Elma Meershoek-Klein Kranenbarg, Hein Putter, Johanna W. van Sandick, Karolina Sikorska, Cornelis J.H. van de Velde, Neil K. Aaronson, Marcel Verheij, and on behalf of the CRITICS Investigators
using neoadjuvant and adjuvant therapy. Most studies reporting on HRQoL in esophagogastric cancer involve patients receiving palliative systemic therapy or surgery alone. 11 – 13 , 22 , 23 The recently published systematic review by Ter Veer et al 23
